Infants with late breast milk acquisition of HIV‐1 generate interferon‐gamma responses more rapidly than infants with early peripartum acquisition

Infants infected with HIV‐1 after the first month of life have a lower viral set‐point and slower disease progression than infants infected before 1 month. We investigated the kinetics of HIV‐1‐specific CD8+ T lymphocyte secretion of interferon (IFN)‐γ in infants infected before 1 month of life compared with those infected between months 1 and 12 (late infection). HIV‐1 infection was assessed at birth and at months 1, 3, 6, 9 and 12 and timing of infection was determined by HIV‐1 gag DNA from dried blood spots and verified by plasma HIV‐1 RNA levels. HIV‐1 peptide‐specific IFN‐γ responses were measured by enzyme‐linked immunospot at months 1, 3, 6, 9 and 12. Timing of development of IFN‐γ responses was compared using the log–rank test and Kaplan–Meier survival curves. Infants infected late developed HIV‐1‐specific CD8+ T cell responses 2·8 months sooner than infants infected peripartum: 2·3 versus 5·1 months after HIV‐1 infection (n = 52, P = 0·04). Late‐infected infants had more focused epitope recognition than early‐infected infants (median 1 versus 2 peptides, P = 0·03); however, there were no differences in the strength of IFN‐γ responses. In infants infected with HIV‐1 after the first month of life, emergence of HIV‐1‐specific CD8+ IFN‐γ responses is coincident with the decline in viral load, nearly identical to what is observed in adults and more rapid than in early‐infected infants.

[1]  S. Rowland-Jones,et al.  Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection. , 2007, The Journal of clinical investigation.

[2]  B. Walker,et al.  Human Immunodeficiency Virus-Specific CD8+ T-Cell Activity Is Detectable from Birth in the Majority of In Utero-Infected Infants , 2007, Journal of Virology.

[3]  D. Nixon,et al.  Strong HIV-1-Specific T Cell Responses in HIV-1-Exposed Uninfected Infants and Neonates Revealed after Regulatory T Cell Removal , 2006, PloS one.

[4]  C. Chougnet,et al.  Defective antigen-presenting cell function in human neonates. , 2006, Clinical immunology.

[5]  W. Fawzi,et al.  Risk of HIV-1 transmission by breastfeeding among mothers infected with recombinant and non-recombinant HIV-1 genotypes. , 2006, Virus research.

[6]  G. Petitjean,et al.  Detection of a large T-cell reservoir able to replicate HIV-1 actively in breast milk , 2006, AIDS.

[7]  E. Holmes,et al.  Unique Acquisition of Cytotoxic T-Lymphocyte Escape Mutants in Infant Human Immunodeficiency Virus Type 1 Infection , 2005, Journal of Virology.

[8]  T. Ndung’u,et al.  Highly active antiretroviral therapy started during pregnancy or postpartum suppresses HIV-1 RNA, but not DNA, in breast milk. , 2005, The Journal of infectious diseases.

[9]  C. Rouzioux,et al.  In HIV type 1-infected children cytotoxic T lymphocyte responses are associated with greater reduction of viremia under antiretroviral therapy. , 2005, AIDS research and human retroviruses.

[10]  S. Rowland-Jones,et al.  Longitudinal Assessment of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific Gamma Interferon Responses during the First Year of Life in HIV-1-Infected Infants , 2005, Journal of Virology.

[11]  R. Kaul,et al.  Screening for HIV-specific T-cell responses using overlapping 15-mer peptide pools or optimized epitopes , 2004, AIDS.

[12]  C. Leclerc,et al.  Neonatal adaptive immunity comes of age , 2004, Nature Reviews Immunology.

[13]  J. Overbaugh,et al.  Predictors of Early Mortality in a Cohort of Human Immunodeficiency Virus Type 1-Infected African Children , 2004, The Pediatric infectious disease journal.

[14]  V. Soriano,et al.  Care of patients with hepatitis C and HIV co-infection. , 2004, AIDS.

[15]  Barbra A. Richardson,et al.  Comparison of Human Immunodeficiency Virus Type 1 Viral Loads in Kenyan Women, Men, and Infants during Primary and Early Infection , 2003, Journal of Virology.

[16]  R. V. van Lier,et al.  Frequencies of Circulating Cytolytic, CD45RA+CD27−, CD8+ T Lymphocytes Depend on Infection with CMV1 , 2003, The Journal of Immunology.

[17]  C. Rouzioux,et al.  Inverse correlation between memory Gag-specific cytotoxic T lymphocytes and viral replication in human immunodeficiency virus-infected children. , 2002, The Journal of infectious diseases.

[18]  C. Rousseau,et al.  Validation of Performance of the Gen-Probe Human Immunodeficiency Virus Type 1 Viral Load Assay with Genital Swabs and Breast Milk Samples , 2002, Journal of Clinical Microbiology.

[19]  B. Richardson,et al.  Salivary secretory leukocyte protease inhibitor is associated with reduced transmission of human immunodeficiency virus type 1 through breast milk. , 2002, The Journal of infectious diseases.

[20]  J. Margolick,et al.  Association of Gag-specific T lymphocyte responses during the early phase of human immunodeficiency virus type 1 infection and lower virus load set point. , 2002, The Journal of infectious diseases.

[21]  H. Whittle,et al.  T cell responses to vaccines in infants: defective IFNγ production after oral polio vaccination , 2002, Clinical and experimental immunology.

[22]  R. Koup,et al.  Analysis of Total Human Immunodeficiency Virus (HIV)-Specific CD4+ and CD8+ T-Cell Responses: Relationship to Viral Load in Untreated HIV Infection , 2001, Journal of Virology.

[23]  R. Schooley,et al.  Relationship between human immunodeficiency virus type 1 (HIV-1)-specific memory cytotoxic T lymphocytes and virus load after recent HIV-1 seroconversion. , 2001, The Journal of infectious diseases.

[24]  B. Richardson,et al.  Morbidity and mortality in breastfed and formula-fed infants of HIV-1-infected women: A randomized clinical trial. , 2001, JAMA.

[25]  L. Jagodzinski,et al.  Evaluation of Performance of the Gen-Probe Human Immunodeficiency Virus Type 1 Viral Load Assay Using Primary Subtype A, C, and D Isolates from Kenya , 2000, Journal of Clinical Microbiology.

[26]  J. Overbaugh,et al.  Rapid Method for Screening Dried Blood Samples on Filter Paper for Human Immunodeficiency Virus Type 1 DNA , 1999, Journal of Clinical Microbiology.

[27]  C. Rouzioux,et al.  Early HIV-specific cytotoxic T lymphocytes and disease progression in children born to HIV-infected mothers. , 1998, AIDS research and human retroviruses.

[28]  M. Barnardo,et al.  Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). , 1995, Tissue antigens.

[29]  D. Ho,et al.  Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome , 1994, Journal of virology.